State Street Corp Green Light Biosciences Holdings, Pbc Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.18 - $0.48 $137,546 - $366,791	-764,148 Reduced 76.11%	239,831 $71,000
Q1 2023 May 15, 2023	SELL	$0.34 - $1.19 $66,721 - $233,524	-196,239 Reduced 16.35%	1,003,979 $431,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.0 $400,151 - $776,994	388,497 Added 47.86%	1,200,218 $1.42 Million
Q3 2022 Nov 15, 2022	BUY	$0.42 - $3.92 $177,154 - $1.65 Million	421,797 Added 108.17%	811,721 $1.88 Million
Q2 2022 Aug 15, 2022	BUY	N/A	191,893 Added 96.9%	389,924 $862,000
Q1 2022 May 16, 2022	BUY	N/A	198,031 New	198,031 $1.91 Million

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.